Pharmaceutical News

RSS

New report presents recommendations to implement public health-based approach to drug policy

A comprehensive new report, Blueprint for a Public Health and Safety Approach to Drug Policy, by The New York Academy of Medicine and the Drug Policy Alliance presents wide-ranging recommendations to implement a public health-based approach to drug policy, calling for strong, effective leadership to make change.

23 Apr 2013

FDA: Balanced Solutions voluntarily recalls sterile non-expireddrug products

Balanced Solutions Compounding Pharmacy, a division of Axium Healthcare Pharmacy, Inc., of Lake Mary, Fla., is voluntarily recalling all lots of its sterile non-expireddrug products due to a lack of sterility assurance and concerns with product quality controls.

23 Apr 2013

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

When thousands of experimental biology researchers gather in Boston this weekend, many of them undoubtedly will be presenting work related to the hunt for the next generation of antibiotics and how to battle back existing and emerging superbugs.

22 Apr 2013

Study: Anesthesia increases success rates of version procedures, decreases cost of delivery

When a baby is in the breech position at the end of pregnancy, obstetricians can sometimes turn the baby head-down to enable a safer vaginal birth.

22 Apr 2013

Study provides medical chemists with tools to design safer drugs, predict their side effects

Yellow vision, pseudo-pulmonary obstruction, involuntary body movements, respiratory paralysis. These are some of the 1,600 known side effects (SEs) produced by drugs.

22 Apr 2013

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Dutch Medical Brands receives first European Class IIa Medical Device Status to treat vaginal infections by using cranberry extracts.

22 Apr 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded BIOTECanada's Gold Leaf Company of the Year Award for 2013.

22 Apr 2013

Aurigene and Endo’s collaborative efforts yield novel drug candidates

Aurigene and Endo entered into collaboration in 2009, for multiple integrated drug discovery programs in the areas of Inflammation and Oncology.

22 Apr 2013

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

The National Foundation for Infectious Diseases will host the 16th Annual Conference on Vaccine Research, April 22-24, 2013, at the Hyatt Regency Inner Harbor in Baltimore, MD.

22 Apr 2013

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

Despite the desperate need for new antibiotics to combat increasingly deadly resistant bacteria, the U.S. Food and Drug Administration (FDA) has approved only one new systemic antibiotic since the Infectious Diseases Society of America (IDSA) launched its 10 x '20 Initiative in 2010 - and that drug was approved two and a half years ago.

22 Apr 2013

New data on safety of nitrous oxide as surgical anesthetic

Giving nitrous oxide as part of general anesthesia for noncardiac surgery doesn't increase the rate of complications and death-and might even decrease the risk of such events, according to a pair of studies in the May issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

22 Apr 2013

Vaccine development expensive but worthy of investment from Congress

During the last three decades, the biopharmaceutical industry has invested significantly in new and improved vaccines, and the collaborative efforts of the [CDC], [the WHO], national governments and industry have led to major progress in addressing global immunization goals and reducing illness and death due to vaccine-preventable diseases.

22 Apr 2013

Bausch + Lomb agrees to commercialize Paragon BioTeck's phenylephrine in US

Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license agreement for Bausch + Lomb to commercialize and distribute Paragon's phenylephrine in the United States on an exclusive basis beginning this month.

20 Apr 2013

Taking painkillers before race leads to unrecognised problems

Many competitors try to prevent pain interfering with their performance by taking painkillers that are readily available in pharmacies and supermarkets, say the authors.

20 Apr 2013

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

High phosphate levels in the blood carry increased heart-related risks, but taking a drug that targets phosphate does not improve cardiovascular measures in patients with mild kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

19 Apr 2013

Long winter months impact tamoxifen treatment for breast cancer

For women diagnosed with a form of breast cancer known as estrogen receptor positive (ER+) breast cancer, tamoxifen is an essential drug used in the treatment and prevention of recurring breast cancer.

19 Apr 2013

Arthritis drug reduces dry eye disease

Dry eye disease (DED) is a common condition that causes discomfort, visual disturbance and potentially damaging ocular surface inflammation that greatly impacts a person's quality of life.

19 Apr 2013

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

In a manuscript published today in Immunity, scientists at the Baylor Institute for Immunology Research (BIIR) and the Benaroya Research Institute at Virginia Mason report the results of a comparative study of the molecular immune responses to influenza and pneumococcal vaccines.

19 Apr 2013

Combination therapies may advance treatment for anaplastic thyroid cancer

A combination of therapies may prove to be a promising advance for the treatment of anaplastic thyroid cancer based on results of a phase I clinical trial, say researchers at Mayo Clinic in Florida.

19 Apr 2013

Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids

Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.

19 Apr 2013

Pharmaceutical News

New report presents recommendations to implement public health-based approach to drug policy

FDA: Balanced Solutions voluntarily recalls sterile non-expireddrug products

Texas scientist says nonmedical community should be educated about long-term effects of antibiotic overuse and misuse

Study: Anesthesia increases success rates of version procedures, decreases cost of delivery

Study provides medical chemists with tools to design safer drugs, predict their side effects

Vaginal infections can be treated and prevented using Cranberry-Active tablets

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Aurigene and Endo’s collaborative efforts yield novel drug candidates

National Foundation for Infectious Diseases to host 16th Annual Conference on Vaccine Research

Time dwindling to meet IDSA goal of 10 new antibiotics by 2020

New data on safety of nitrous oxide as surgical anesthetic

Vaccine development expensive but worthy of investment from Congress

Bausch + Lomb agrees to commercialize Paragon BioTeck's phenylephrine in US

Taking painkillers before race leads to unrecognised problems

Drug that targets phosphate does not improve CVD measures in patients with mild kidney disease

Long winter months impact tamoxifen treatment for breast cancer

Arthritis drug reduces dry eye disease

BIIR researchers report results of comparative study of molecular immune responses to influenza and pneumococcal vaccines

Combination therapies may advance treatment for anaplastic thyroid cancer

Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News